Skip to main content

Tripos Shares Up 21 Percent on News It Will Sell Informatics Business

NEW YORK (GenomeWeb News) — Shares in Tripos were up 21 percent, or $.13, at $.74 in mid-afternoon trading after the company said it has found a buyer for its Discovery Informatics business.
 
As GenomeWeb News reported this morning, Tripos said it will sell the division to Venture for $26.5 million in cash and it said it expects to distribute between $6 million and $12 million to its shareholders when the sale closes.
 
The company stated last week it is looking to sell its Discovery Research business as well.
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.